Stay updated on Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Sign up to get notified when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.

Latest updates to the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page
- Check4 days agoChange DetectedThe page shows Revision: v3.3.4 replacing v3.3.3 with no changes to study content or essential features. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedLocations section updated to include Guangdong and Hubei locations; revision noted as v3.3.3.SummaryDifference0.4%

- Check54 days agoChange DetectedRevision: v3.3.2 is now shown, replacing the previous Revision: v3.2.0.SummaryDifference0.1%

- Check61 days agoChange DetectedThe government funding/operating status notice was removed from the page, an administrative update that does not affect the trial’s core content or data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check75 days agoChange DetectedNo significant changes to the study details, eligibility criteria, enrollment, or outcomes were detected; the content and purpose of the page remain the same. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check104 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference3%

Stay in the know with updates to Sintilimab Plus Chidamide in ENKTCL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sintilimab Plus Chidamide in ENKTCL Clinical Trial page.